- Statement of Commissioner Rebecca Kelly Slaughter Regarding FTC Staff Interim Report: Pharmacy Benefit Managers ( )
- Concurring Statement of Commissioner Andrew N. Ferguson Regarding the Pharmacy Benefit Managers Interim Staff Report ( )
- Statement of Chair Lina M. Khan Joined by Commissioners Alvaro M. Bedoya & Rebecca Kelly Slaughter Regarding the Pharmacy Benefit Managers Interim Staff Report ( )
- Dissenting Statement of Commissioner Melissa Holyoak In the Matter of the Pharmacy Benefit Managers Report ( )
- Chair Khan Opening Statement at House Committee on Appropriations , Subcommittee on Financial Services and General Government ( )
- Concurring Statement of Commissioner Alvaro M. Bedoya in the Matter of ExxonMobil Co./Pioneer Natural Resource Co. ( )
- Concurring Statement of Commissioner Rebecca Kelly Slaughter in the Matter of ExxonMobil Corp ( )
- Joint Dissenting Statement of Commissioners Melissa Holyoak and Andrew N. Ferguson in the Matter of Exxon Mobil Corporation ( )
- Statement of Chair Lina M. Khan in the Matter of Exxon Mobil Corporation ( )
- Reply Comment of the U.S. Department of Justice Antitrust Division and the Federal Trade Commission ( )
- Remarks by Chair Lina M. Khan as Prepared for Delivery at Harvard Center for Labor and a Just Economy ( )
- Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding the FY2022 HSR Annual Report to Congress ( )
- Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter In the Matter of Sanofi/Maze Therapeutics ( )
- Remarks of Chair Lina M. Khan as Prepared for Delivery at the Fordham 50th Annual Conference on International Antitrust Law & Policy ( )
- Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc ( )
- Statement of Chair Lina M. Khan, Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya, in the Matter of EQT Corporation ( )
- Remarks of Chair Lina M. Khan at Economic Club of New York ( )
- Statement of Commissioner Alvaro M. Bedoya Joined by Chair Lina M. Khan and Commissioner Rebecca Kelly Slaughter Regarding the Proposed Merger Guidelines Issued by the Federal Trade Commission & U.S. Department of Justice ( )
- Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines ( )
- FTC-DOJ Merger Guidelines (Draft for Public Comment) ( )
- Statement Of Commissioner Rebecca Kelly Slaughter Joined by Chair Lina M. Khan and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines ( )
- Statement of Chair Lina M. Khan Joined by Commissioners Slaughter and Bedoya Regarding Proposed Amendments to the Premerger Notification Form and the Hart-Scott-Rodino Rules ( )
- Statement of Commissioner Alvaro M. Bedoya Joined by Commissioner Rebecca Kelly Slaughter Regarding Amazon.com, Inc.'s Acquisition of 1Life Healthcare, Inc. ( )
- Joint Statement of Chair Khan, Commissioner Slaughter, Commissioner Wilson, and Commissioner Bedoya, Regarding Amazon.com, Inc.'s Acquisition of 1Life Healthcare, Inc. ( )
- Statement of Commissioner Christine S. Wilson Regarding the FY2021 HSR Annual Report ( )
- Statement of Commissioner Rebecca Kelly Slaughter, Joined by Chair Lina M. Khan and Commissioner Alvaro M. Bedoya, Regarding the FY2021 HSR Annual Report ( )
- Remarks by Holly Vedova at 12th Annual GCR Live: Law Leaders Global Conference ( )
- Dissenting Statement of Commissioner Christine S. Wilson Regarding the Petition for Recusal of Chair Lina M. Khan from Involvement in the Matter of Meta/Zuckerberg/Within ( )
- Statement of Chair Lina M. Khan Regarding the Petition for Recusal from Involvement in the Proposed Merger Between Meta Platforms, Inc. and Within Unlimited, Inc. (Approved for Publication by Commission Vote) ( )
- Statement of Commissioner Rebecca Kelly Slaughter Joined by Chair Lina M. Khan ( )
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.